Your web browser is out of date.

For your security and improved experience online, please update your browser.

This site is intended for healthcare professionals only
×
Share this article
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email
Share on print
Print

Open-source versus commercial automated insulin delivery systems

Real-world study comparing the efficacy and user characteristics of open-source versus commercially available closed-loop insulin delivery systems.

The do-it-yourself artificial pancreas movement, in which users create their own closed-loop insulin delivery systems using commercially available continuous glucose monitoring and insulin pump systems combined with open-source software, is growing, with an estimated 9000 users worldwide despite the systems’ unregulated status. This real-world, observational study compared the efficacy and user characteristics of open-source systems versus the first commercially available hybrid closed-loop system (approved in Europe in 2018).

Data from 68 adults with type 1 diabetes who switched to closed-loop systems from sensor-augmented pump therapy (38 using the commercial system and 30 using various open-source systems) were evaluated. Compared with commercial users, open-source users were younger (age 41 vs 47 years), had a shorter duration of diabetes (25 vs 31 years), were more likely to be male (70% vs 32%), had a lower mean HbA1c at the time of switching (54 vs 62 mmol/mol) and had a higher education status despite similar socio-economic status scores.

Both groups saw their HbA1c fall at 6 months of follow-up, but the open-source group had a greater reduction (9.8 vs 1.1 mmol/mol). The open-source group also had a greater percentage of Time In Range (79% vs 68%) and a lower percentage of Time Above Range (18% vs 29%). However, there was a small but significant increase in time spent with glucose levels <3.0 mmol/L (0.3% vs 0.0%). Open-source users also had higher total daily doses of insulin (0.6 vs 0.5 units/kg) and experienced more weight gain (median weight change +1.25 kg vs –0.3 kg) despite similar reported carbohydrate intake.

The authors observed no safety concerns with the open-source systems; however, the study highlights high rates of out-of-warranty insulin pump use and use of flash glucose monitors with unregulated algorithms.

The authors conclude that do-it-yourself closed-loop insulin delivery systems had a similar efficacy and safety to the commercially approved system, and that these data provide support for the use of these systems in motivated individuals demonstrating a high level of self-care.

Click here to read the study in full.

Share this article
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
For the latest news and articles

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for UK healthcare professionals only. To continue, please confirm that you are a UK healthcare professional below.